Zoetis Inc. $ZTS Shares Purchased by Everpar Advisors LLC

Everpar Advisors LLC boosted its stake in Zoetis Inc. (NYSE:ZTS) by 11.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,677 shares of the company’s stock after acquiring an additional 174 shares during the period. Everpar Advisors LLC’s holdings in Zoetis were worth $262,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in ZTS. Nova Wealth Management Inc. bought a new stake in Zoetis during the first quarter valued at $25,000. 1248 Management LLC bought a new stake in Zoetis during the first quarter valued at $27,000. Saudi Central Bank bought a new stake in Zoetis during the first quarter valued at $29,000. Cornerstone Planning Group LLC increased its stake in Zoetis by 79.3% during the first quarter. Cornerstone Planning Group LLC now owns 199 shares of the company’s stock valued at $30,000 after purchasing an additional 88 shares during the last quarter. Finally, Migdal Insurance & Financial Holdings Ltd. increased its stake in Zoetis by 87.6% during the first quarter. Migdal Insurance & Financial Holdings Ltd. now owns 257 shares of the company’s stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Stock Performance

NYSE:ZTS opened at $147.44 on Wednesday. Zoetis Inc. has a twelve month low of $139.70 and a twelve month high of $200.33. The company has a current ratio of 1.76, a quick ratio of 1.04 and a debt-to-equity ratio of 1.05. The company has a 50-day moving average of $151.90 and a 200-day moving average of $156.99. The firm has a market cap of $65.34 billion, a price-to-earnings ratio of 25.38, a price-to-earnings-growth ratio of 2.35 and a beta of 0.89.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.14. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. The company had revenue of $2.46 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter last year, the firm posted $1.56 EPS. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts forecast that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ZTS. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $180.00 to $155.00 in a research note on Thursday, July 17th. Stifel Nicolaus lowered shares of Zoetis from a “buy” rating to a “hold” rating and lowered their target price for the company from $165.00 to $160.00 in a research note on Wednesday, June 18th. Piper Sandler boosted their target price on shares of Zoetis from $210.00 to $215.00 and gave the company an “overweight” rating in a research note on Monday, August 11th. Argus restated a “buy” rating and set a $190.00 price target on shares of Zoetis in a research report on Tuesday, September 9th. Finally, Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research report on Thursday, July 17th. Five research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $200.88.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.